Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Shareholders' Equity (Details) - Schedule of Weighted Average Exercise Prices Share Options

v3.24.2.u1
Shareholders' Equity (Details) - Schedule of Weighted Average Exercise Prices Share Options - $ / shares
6 Months Ended
Dec. 31, 2023
Jun. 30, 2024
Schedule of Weighted Average Exercise Prices Share Options [Abstract]    
Number of options, Grants (in Shares)   9,000,000
Weighted average exercise price, Grants   $ 0
Weighted average remaining contractual terms, Grants   9 years 10 months 6 days
Aggregate intrinsic value , Grants  
Number of options, Forfeited/expired (in Shares)   (5,412,500)
Weighted average exercise price, Forfeited/expired  
Aggregate intrinsic value, Forfeited/expired  
Number of options, Ending (in Shares) 82,477,000 86,064,500
Weighted average exercise price, Ending $ 0.04 $ 0.04
Weighted average remaining contractual terms, Ending 8 years 4 months 24 days 5 years 7 months 6 days
Aggregate intrinsic value, Ending $ 0.04
Number of options, Vested and expected to vest (in Shares)   86,064,500
Weighted average exercise price, Vested and expected to vest   $ 0.04
Weighted average remaining contractual terms, Vested and expected to vest   5 years 7 months 6 days
Aggregate intrinsic value, Vested and expected to vest   $ 0.04
Number of options, Exercisable (in Shares)   33,998,875
Weighted average exercise price, Exercisable   $ 0.08
Weighted average remaining contractual terms, Exercisable   5 years 4 months 24 days
Aggregate intrinsic value, Exercisable